CM
VRNA

Caption Management’s Verona Pharma VRNA Stock Holding History

Caption Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73,900
Closed -$4.69M – 1936
2025
Q1 		$4.69M Sell
73,900
-183,700
-71% -$11M 0.05% 411
2024
Q4 		$12M Buy
257,600
+217,600
+544% +$8.17M 0.11% 154
2024
Q3 		$1.15M Sell
40,000
-100,000
-71% -$2.46M 0.02% 739
2024
Q2 		$2.02M Buy
+140,000
New +$2.04M 0.03% 473
2023
Q2 		– Sell
-20,000
Closed -$402K – 1430
2023
Q1 		$402K Sell
20,000
-175,100
-90% -$3.78M 0.01% 832
2022
Q4 		$5.1M Buy
195,100
+120,100
+160% +$1.6M 0.08% 298
2022
Q3 		$767K Buy
+75,000
New +$632K 0.01% 955

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caption Management's VRNA Position: Q3 2025 in Review

Caption Management sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 5,351 shares — an estimated $506K sold.

Caption Management first reported a position in VRNA in Q2 2023 and held it in 5 quarters. The position peaked at $3.22M in Q3 2024. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Caption Management reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 5,351 Verona Pharma shares in Q3 2025, an estimated $506K.
  • Caption Management first reported a position in Verona Pharma in Q2 2023 and held it in 5 quarters.
  • Caption Management's Verona Pharma position peaked at $3.22M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.